ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2,1,Headache,Headaches NEC,Headaches,Nerv,N
2,2,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
3,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
3,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
3,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
3,4,Weight abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
4,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
4,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
4,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
6,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
7,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
8,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
8,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
8,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
8,4,Communication disorder,Communications disorders,Communication disorders and disturbances,Psych,N
8,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
8,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
8,7,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
8,8,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8,9,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
8,10,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
8,11,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
8,12,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
8,13,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
8,14,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
8,15,Inflammation,Inflammations,General system disorders NEC,Genrl,N
8,16,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
8,17,Lung hypoinflation,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
8,18,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8,19,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
8,20,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
8,21,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
8,22,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
8,23,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
9,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
9,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
9,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
9,4,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
9,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
9,6,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
10,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
10,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11,1,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
12,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
12,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
13,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
13,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
14,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
15,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
16,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
16,2,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
17,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
18,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
18,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
18,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
18,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
19,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
19,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
19,3,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
19,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
20,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
20,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
20,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
21,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
21,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
22,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
22,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
23,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
23,2,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
23,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
23,4,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
23,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,6,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
23,7,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
23,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
24,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
24,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
24,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
24,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
24,5,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
24,6,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
25,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
26,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
27,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
28,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
29,1,Oxygen consumption decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
30,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
30,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
30,3,Headache,Headaches NEC,Headaches,Nerv,N
31,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
32,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
